JohnJMarianiMD
Psychiatry • New York, NYAddiction
Associate Professor of Clinical Psychiatry Columbia University Medical Center
Dr. Mariani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
51 East 25th Street
STE 7E
New York, NY 10010Phone+1 646-609-6771Fax+1 646-588-1984- Is this information wrong?
Education & Training
New York-Presbyterian HospitalFellowship, Addiction Psychiatry Research, 2003 - 2005
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Psychiatry, 2003- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Obstetrics and Gynecology, 1993 - 1995
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Obstetrics and Gynecology, 1993 - 1994
New York University School of MedicineClass of 1993
State University of New York at AlbanyBS, Biology, 1985 - 1989
Certifications & Licensure
NY State Medical License 1995 - 2026- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients Start of enrollment: 2007 Jan 01
- Study of Quetiapine Treatment for Cannabis Dependence Start of enrollment: 2009 Aug 01
- Gabapentin for Abstinence Initiation in Alcohol Dependence Start of enrollment: 2010 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Treating Attention-Deficit/Hyperactivity Disorder Matters.Frances R Levin, Mariely Hernandez, John J Mariani> ;JAMA. 2024 Mar 12
- Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs.John J Mariani, Robert L Dobbins, Amy Heath, Frank Gray, Howard Hassman> ;The American Journal on Addictions. 2024 Jan 1
- Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder.John J Mariani, Cale Basaraba, Martina Pavlicova, Daniel M Alschuler, Daniel J Brooks, Amy L Mahony, Christina Brezing, Nasir H Naqvi, Frances R Levin> ;The American Journal of Drug and Alcohol Abuse. 2023 Sep 3
- Join now to see all
Journal Articles
- American Psychiatric Association PublishingAdam Bisaga, Frances R Levin, John J Mariani, Maria A Sullivan, Edward V Nunes, National Institutes of Health
Press Mentions
The Non-Alcoholic’s Guide to Drinking Less AlcoholNovember 3rd, 2017
CUIMC Update - January 10, 2024January 13th, 2024- One-Day Induction of XR Buprenorphine Feasible for Fentanyl Use in OUDNovember 10th, 2023
- Join now to see all
Grant Support
- Quetiapine Pharmacotherapy for Cannabis DependenceNational Institute on Drug Abuse2012–Present
- Gabapentin For Abstinence Initiation In Alcohol DependenceNational Institute On Alcohol Abuse And Alcoholism2010–2011
- Anticonvulsant Pharmacotherapy For Sedative-Hypnotic Use DisordersNational Institute On Drug Abuse2006–2010
Research History
- Director, Substance Treatment and Research Service (STARS) of Columbia University Medical Center Department of PsychiatryThe Substance Treatment and Research Service of Columbia University Medical Center Department of Psychiatry is a facility for conducting clinical trials evaluating potential treatments for substance use disorders and co-occurring conditions.2005 - Present
Hospital Affiliations
- New York State Psychiatric InstituteNew York, New York
External Links
- Columbia Facultyhttp://asp.cumc.columbia.edu/facdb/profile_list.asp?uni=jm2330&DepAffil=Psychiatry
- Private Practicehttps://www.johnmarianimd.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
